https://www.auntminnie.com/clinical-news/ct/article/16425113/lungrads-may-speed-diagnosis-of-cystic-airspace-lung-cancerAuntMinnieen2026-11-10T20:26:55.000ZLung-RADS may speed diagnosis of cystic airspace lung cancerhttps://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/11/ca-lung-cancer.OnlmzvjrnL.jpg?auto=format%252Ccompress&q=70Examples of the potential application of the Lung Imaging Reporting and Data System (Lung-RADS) 2022 criteria for earlier identification of lung cancer associated with cystic airspaces (CA) manifesting as atypical pulmonary cysts and corresponding management recommendations to anticipate diagnostic work-up for three participants from the National Lung Screening Trial. Application of Lung-RADS 2022 to serial low-dose CT (LDCT) examinations could have led to potential diagnostic anticipation in 80% (24 of 30) of unilocular cysts with associated nodule, 53% (10 of 19) of thick-walled unilocular cysts, and 88% (21 of 24) of multilocular cyst. <strong>(A)</strong> Participant 54, a 64-year-old female. Baseline LDCT scan (T0) shows a multilocular atypical pulmonary cyst (thick arrow) in the right upper lobe, consistent with a Lung-RADS 2022 category 4A (suspicious) lesion, according to which 3-month LDCT would have been recommended. At the first annual repeat examination (T1), two solid nodules (8.4 and 4.4 mm) (thin arrows) appeared within the cyst, consistent with lung cancer associated with CA and a Lung-RADS category 4B (very suspicious) lesion, according to which diagnostic CT, PET/CT, or tissue sampling would have been recommended 1 year after the baseline LDCT examination. At the next annual repeat examination (T2), the lesion reverted to a solid mass, consistent with a category 4B lesion. A screening-detected stage IV adenocarcinoma was diagnosed 2 years after the baseline LDCT examination and was the cause of death 3 months later. <strong>(B)</strong> Participant 44, a 66-year-old male. Baseline LDCT scan (T0) shows a large unilocular cyst with a small (4.8-mm), thick-walled nodule (arrow) in the right upper lobe, consistent with the features of an atypical pulmonary cyst with a thick wall and qualifying the lesion as a Lung-RADS 2022 category 4A (suspicious) lesion, according to which 3-month LDCT would have been recommended. At the first annual repeat examination (T1), the nodule had grown more than 1.5 mm, consistent with a category 4B (very suspicious) lesion according to Lung-RADS 2022; diagnostic CT, PET/CT, or tissue sampling would have been recommended 1 year after the baseline examination. At the second annual repeat examination (T2), elongated thickening of the adjacent cyst wall was observed, consistent with a category 4B lesion as per Lung-RADS 2022. A non–screening-detected stage IIA squamous cell carcinoma was ultimately diagnosed 2.6 years after the baseline LDCT examination and was the cause of death 3.3 years later. <strong>(C)</strong> Participant 43, a 70-year-old male. Baseline LDCT scan (T0) shows paraseptal emphysema areas in the right lower lobe. The first annual repeat LDCT examination (T1) shows thickening (arrow) of the airspace walls by more than 1.5 mm, consistent with an atypical pulmonary cyst and qualifying for a category 4B (very suspicious) lesion according to Lung-RADS 2022; diagnostic CT, PET/CT, or tissue sampling would have been recommended 1 year after the baseline LDCT examination. At the second annual repeat examination (T2), the solid components had almost filled the airspace. A screening-detected stage IV squamous cell carcinoma was ultimately diagnosed 2.6 years after baseline LDCT and was the cause of death 10 months later.https://www.auntminnie.com/clinical-news/mri/article/16425115/7t-mri-finds-more-ms-lesionsAuntMinnieen2026-11-10T20:26:04.000Z7T MRI finds more MS lesionshttps://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/11/images-radiol260473fig2.3l2nlWpR1y.jpg?auto=format%252Ccompress&q=70Multiple sclerosis (MS) lesions: 7T versus 3T MRI. MRI scans of cortical lesions in two participants with relapsing-remitting MS: <strong>(A)</strong> 34-year-old female and <strong>(B)</strong> 56-year-old female. For each participant, axial magnified views at 7T and 3T MRI show the lesion (white arrowheads), with insets showing the corresponding anatomic location (yellow arrowheads). The MS lesion is clearly visible at 7T MRI but difficult to visualize at 3T MRI. FLAIR = fluid-attenuated inversion recovery, T1WI = T1-weighted imaging, T2WI = T2-weighted imaging.https://www.auntminnie.com/resources/minnies/article/16425021/familiar-themes-resurface-again-in-2026-minniesAuntMinnieen2026-11-10T19:45:00.000ZFamiliar themes resurface again in 2026 Minnieshttps://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/11/minnies-logo-winner-social.eprMQY5lMk.jpg?auto=format%252Ccompress&q=70https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/11/img-2704.t52vrOIkl2.png?auto=format%252Ccompress&q=70Amy Patel, MDhttps://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/11/jason-theadore.OlHylapeCR.png?auto=format%252Ccompress&q=70Jason Theadorehttps://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/11/pickhardt-perry-072126.sc90Pd7dV6.jpg?auto=format%252Ccompress&q=70Perry Pickhardt, MDhttps://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/11/headshotbonfigbecker2022.eLKrr0ErS7.jpg?auto=format%252Ccompress&q=70Holly Bonfig-Becker, Ed.D, RT(R)(M)https://www.auntminnie.com/clinical-news/article/16425013/minnies-winners-for-2026-page-3AuntMinnieen2026-11-10T19:45:00.000ZMinnies winners for 2026, Page 3https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/11/best-software-bracco-aimify.10fj0N2E9o.png?auto=format%252Ccompress&q=70https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/11/magnetvision-pro.hyxYKOLJA6.png?auto=format%252Ccompress&q=70<i>Top of GE 450W 1.5T MR scanner rendered invisible with 6’ tall 70 kg patient positioned in the bore for an MRI examination of the brain. The strength and spatial distribution of the transmitted radiofrequency oscillating magnetic fields of an unloaded body coil for this model MR scanner color coded are superimposed on our “patient" to demonstrate the areas of highest and lowest direct RF-irradiation exposure levels.  This helps explain why, when using the body RF coil for RF transmission for a brain MRI examination, the patient can develop a severe proximity  at the upper outer aspects of the shoulder and arms where there is intense exposure to direct B1 (RF) irradiation intensities (shown in white) and, therefore, strong induced electrical fields and currents.</i>https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/11/prism-screenshot.uWGTlK0p4c.png?auto=format%252Ccompress&q=70<i>Shadowfax’s Prism reporting workspace brings patient context, prior-study findings, comparison tools, and report editing into a single interface. Demonstration case with fictional patient information.</i>https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/11/gehc-photonova-spectra.8l1vxs2sYh.jpg?auto=format%252Ccompress&q=70GE HealthCare's Photonova Spectra photon-counting CT scanner.https://www.auntminnie.com/clinical-news/article/16425012/minnies-winners-for-2026-page-2AuntMinnieen2026-11-10T19:45:00.000ZMinnies winners for 2026, Page 2https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/11/screenshot-2026-11-09-123109.c2alb6ni5n.png?auto=format%252Ccompress&q=70https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/11/ummc-shrp-1.8FyUCbRgKU.png?auto=format%252Ccompress&q=70https://www.auntminnie.com/clinical-news/ct/article/16424999/iodine-use-can-be-cut-in-postmortem-ct-angiographyAuntMinnieen2026-11-09T21:49:03.000ZIodine use can be cut in postmortem CT angiographyhttps://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/11/iodine-reduced-120ml.Y30B5pqjYW.jpg?auto=format%252Ccompress&q=70Example of a case with a dilution of 120 ml and a BMI of 31.1 kg/m2: a clinical setting (ww:565; wl:103); b window width and window level and setting (ww:469;wl:81) used for radiological interpretation.https://www.auntminnie.com/clinical-news/interventional/article/16424982/uae-helps-women-with-fibroids-adenomyosis-avoid-surgeryAuntMinnieen2026-11-09T20:37:09.000ZUAE helps women with fibroids, adenomyosis avoid surgeryhttps://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/11/uterus-pelvic-400-2.bLIOPCzsZZ.jpg?auto=format%252Ccompress&q=70https://www.auntminnie.com/editors-note/article/16424576/week-in-review-cms-final-2027-rules-lung-cancer-brain-metastases-new-podcastsAuntMinnieen2026-11-06T21:54:50.000ZWeek in Review: CMS final 2027 rules | Lung cancer brain metastases | New podcastshttps://www.auntminnie.com/clinical-news/mri/article/16424565/gadoxetic-acidenhanced-mri-changing-understanding-of-liver-diseasesAuntMinnieen2026-11-06T21:50:47.000ZGadoxetic acid-enhanced MRI changing understanding of liver diseaseshttps://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/11/liver-gallbladder-400.5qRXZxT729.jpg?auto=format%252Ccompress&q=70https://www.auntminnie.com/clinical-news/ct/article/16424554/deeplearning-model-predicts-mortality-from-cta-scansAuntMinnieen2026-11-06T19:29:57.000ZDeep-learning model predicts mortality from CTA scanshttps://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/11/cac-ai-model.5zit2QCAiF.jpg?auto=format%252Ccompress&q=70Comparison of deep learning segmentation (A) with quantitative histology (B) using Movat's Pentachrome staining (red = fibrotic tissue; yellow = calcific tissue; blue = aortic lumen), demonstrating excellent agreement between methods (C) for quantification of aortic valve composition. Fibrotic tissue is expressed as a percentage and was calculated as [(tissue component volume/total tissue volume) × 100].https://www.auntminnie.com/resources/conference/rsna/2026/digital-xray-preview/article/16424534/coming-soon-rsna-2026-digital-xray-previewAuntMinnieen2026-11-06T16:55:50.000ZComing Soon - RSNA 2026 Digital XRay Previewhttps://www.auntminnie.com/clinical-news/womens-imaging/article/16424514/screening-breast-mri-may-be-considered-for-highrisk-womenAuntMinnieen2026-11-06T16:12:40.000ZScreening breast MRI may be considered for high-risk womenhttps://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/11/mri-breast-400.GA5HSTyScT.jpg?auto=format%252Ccompress&q=70https://www.auntminnie.com/resources/webinars/article/16424468/philps-healthcare-informatics-radiology-workspace-boost-productivity-and-elevate-clinical-outcomesAuntMinnieen2026-11-05T21:00:45.000ZRadiology Workspace: boost productivity and elevate clinical outcomeshttps://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/11/radiology-workspace-philips-white.xI8TrEYSCp.png?auto=format%252Ccompress&q=70https://www.auntminnie.com/resources/webinars/article/16424463/bayer-healthcare-ct-contrast-injection-reimagined-precision-personalization-in-practiceAuntMinnieen2026-11-05T20:35:23.000ZCT Contrast Injection Reimagined- Precision Personalization in Practicehttps://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/11/400x300-11.l92OveefB2.png?auto=format%252Ccompress&q=70https://www.auntminnie.com/clinical-news/molecular-imaging/nuclear-medicine/article/16424445/what-are-patients-being-told-before-during-and-after-lu177-rptAuntMinnieen2026-11-05T20:31:29.000ZWhat are patients being told before, during, and after Lu-177 RPT?https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/11/patient.D9SUEKzZvD.jpg?auto=format%252Ccompress&q=70https://www.auntminnie.com/practice-management/article/16424413/cms-final-rule-draws-mixed-responseAuntMinnieen2026-11-05T18:02:21.000ZCMS final rule draws mixed responsehttps://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/11/cms-building-400.bVFxz7NhF3.jpg?auto=format%252Ccompress&q=70https://www.auntminnie.com/clinical-news/molecular-imaging/nuclear-medicine/article/16424342/lu177-fap2286-controls-lung-cancer-brain-metastasesAuntMinnieen2026-11-04T21:36:53.000ZLu-177 FAP-2286 controls lung cancer brain metastaseshttps://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/11/fap-2286-brain-metasteses.QX2QI821cJ.jpg?auto=format%252Ccompress&q=70Lu-177 FAP-2286 metabolism activity response pre-treatment and post-treatment in patient 2. Pretreatment Ga-68 FAP-2286 PET/CT imaging showed tracer uptake in the right frontal lobe lesion (SUVmax = 3.86, SULpeak = 2.01) (A–D). Pretreatment F-18 FDG-PET/CT imaging showed intense tracer uptake in the right frontal lobe lesion and perilesional edema (E–H). After 2 cycles of Lu-177 FAP-2286 treatment, the lesion significantly resolved, meeting intracranial CMR criteria (I–L).https://www.auntminnie.com/resources/conference/rsna/2026/artificial-intelligence-preview/article/16424329/coming-soon-rsna-2026-artificial-intelligence-previewAuntMinnieen2026-11-04T20:19:05.000ZComing Soon - RSNA 2026 Artificial Intelligence Previewhttps://www.auntminnie.com/resources/conference/rsna/2026/advanced-visualization-preview/article/16424283/coming-soon-2026-rsna-advanced-visualization-previewAuntMinnieen2026-11-04T17:36:59.000ZComing Soon - 2026 RSNA Advanced Visualization Previewhttps://www.auntminnie.com/resources/conference/rsna/2026/womens-imaging-preview/article/16424264/coming-soon-rsna-2026-womens-imaging-previewAuntMinnieen2026-11-04T16:52:50.000ZComing Soon - RSNA 2026 Women's Imaging Previewhttps://www.auntminnie.com/resources/conference/rsna/2026/ultrasound-preview/article/16424263/coming-soon-rsna-2026-ultrasound-previewAuntMinnieen2026-11-04T16:52:13.000ZComing Soon - RSNA 2026 Ultrasound Previewhttps://www.auntminnie.com/resources/conference/rsna/2026/molecular-imaging-preview/article/16424262/coming-soon-rsna-2026-molecular-imaging-previewAuntMinnieen2026-11-04T16:51:11.000ZComing Soon - RSNA 2026 Molecular Imaging Previewhttps://www.auntminnie.com/resources/conference/rsna/2026/mri-preview/article/16424260/coming-soon-rsna-2026-mri-previewAuntMinnieen2026-11-04T16:50:20.000ZComing Soon - RSNA 2026 MRI Previewhttps://www.auntminnie.com/resources/conference/rsna/2026/imaging-informatics-preview/article/16424258/coming-soon-rsna-2026-imaging-informatics-previewAuntMinnieen2026-11-04T16:48:46.000ZComing Soon - RSNA 2026 Imaging Informatics Previewhttps://www.auntminnie.com/resources/conference/rsna/2026/ct-preview/article/16424253/coming-soon-rsna-2026-ct-previewAuntMinnieen2026-11-04T16:45:48.000ZComing Soon - RSNA 2026 CT Previewhttps://www.auntminnie.com/resources/conference/rsna/2026/artificial-intelligence-preview/article/16424252/coming-soon-rsna-2026-coverageAuntMinnieen2026-11-04T16:44:52.000ZComing Soon - RSNA 2026 Coveragehttps://www.auntminnie.com/clinical-news/molecular-imaging/article/16424170/immunopetct-detects-myeloma-missed-by-fdgpetctAuntMinnieen2026-11-03T21:56:15.000ZImmuno-PET/CT detects myeloma missed by FDG-PET/CThttps://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/11/multiple-myeloma-tracer.giQJcaydbB.jpg?auto=format%252Ccompress&q=70Images in a 69-year-old man with multiple myeloma detected with Zr-89 deferoxamine (DFO)-daratumumab PET but not with F-18 FDG-PET. (A) Maximum intensity projection image from F-18 FDG-PET/CT shows no foci of disease. Physiologic F-18 FDG uptake is seen in the brain, blood pool, liver, and urinary tract. (B) Maximum intensity projection image from Zr-89 DFO-daratumumab PET/CT demonstrates more than 100 foci that are localized to bone (arrows), consistent with osseous myeloma. Physiologic uptake is seen in the liver and spleen. Sagittal (C) CT, (D) Zr-89 DFO-daratumumab PET, and (E) fused Zr-89 DFO-daratumumab PET/CT images demonstrate localization of multiple foci to bone. Subsequent biopsy of the right ilium confirmed active CD38-positive myeloma. Color bars show standardized uptake value.